Mortel K F, Meyer J S, Rauch G M, Konno S, Haque A, Rauch R A
Veterans Affairs Medical Center, Houston, TX, USA.
J Stroke Cerebrovasc Dis. 1999 Mar-Apr;8(2):57-65. doi: 10.1016/s1052-3057(99)80055-x.
Vascular dementia (VAD) and dementia of the Alzheimer type (DAT) are malignant conditions of the elderly. More information is required to clarify expected lengths of survival, which condition is more lethal, and which risk factors may influence survival duration.
Cross-sectional and longitudinal designs were used. Survival interval was the period after study admission to death. From a population of 392 patients (of the 150 patients with VAD, mean age at entry was 68.3 years, of the 242 patients with DAT, mean age at entry was 73.0 years), there were 52 deaths, 26 patients with VAD and 26 patients with DAT. Pre-entry dementia symptoms were present for a mean of 3.1 years, with median follow-up of 3.6 years. Among 236 control subjects, there were 19 deaths. Entry age was 69.5 years, with median follow-up of 8.8 years. Influences of risk factors for stroke and body mass index on symptom duration, survival intervals, and cause of death were evaluated.
Family history of neurodegenerative disorders, principally DAT, negatively influenced DAT survival. Body mass index declined with age and duration of pre-entry symptoms among men and women in all three groups. Before entry, for men, dementia symptoms were present for shorter periods compared with women. After entry, VAD and DAT patients had similar survival intervals. Causes of death were similarly distributed (78% of patients with VAD died from vascular causes, 56% of patients with DAT and 67% of the controls).
VAD and DAT are malignant conditions negatively influencing survival times. Being a woman seems to play a protective role in symptom duration before diagnosis, but after diagnosis survival times of men and women were similar. We attribute equivalence of survival intervals among dementia groups to control of risk factors for cerebrovascular disease.
血管性痴呆(VAD)和阿尔茨海默病型痴呆(DAT)是老年人的恶性疾病。需要更多信息来明确预期生存时长、哪种疾病更具致死性以及哪些风险因素可能影响生存时间。
采用横断面和纵向设计。生存间隔是从研究入组至死亡的时间段。在392例患者中(150例VAD患者,入组时平均年龄68.3岁;242例DAT患者,入组时平均年龄73.0岁),有52例死亡,其中26例VAD患者和26例DAT患者。入组前痴呆症状平均存在3.1年,中位随访时间为3.6年。在236例对照受试者中,有19例死亡。入组年龄为69.5岁,中位随访时间为8.8年。评估了中风风险因素和体重指数对症状持续时间、生存间隔及死亡原因的影响。
神经退行性疾病家族史,主要是DAT家族史,对DAT患者的生存有负面影响。在所有三组中,男性和女性的体重指数均随年龄和入组前症状持续时间下降。入组前,男性的痴呆症状出现时间比女性短。入组后,VAD和DAT患者的生存间隔相似。死亡原因分布相似(78%的VAD患者死于血管性原因,56%的DAT患者和67%的对照受试者)。
VAD和DAT是对生存时间有负面影响的恶性疾病。女性在诊断前的症状持续时间方面似乎起到保护作用,但诊断后男性和女性的生存时间相似。我们将痴呆组间生存间隔的等同归因于对脑血管疾病风险因素的控制。